RBC Capital analyst Conor McNamara reiterates Thermo Fisher Scientific (NYSE:TMO) with a Outperform and maintains $767 price target.
RBC Capital Reiterates Outperform on Thermo Fisher Scientific, Maintains $767 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.